These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28751743)

  • 1. Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.
    Borroni B; Stanic J; Verpelli C; Mellone M; Bonomi E; Alberici A; Bernasconi P; Culotta L; Zianni E; Archetti S; Manes M; Gazzina S; Ghidoni R; Benussi L; Stuani C; Di Luca M; Sala C; Buratti E; Padovani A; Gardoni F
    Sci Rep; 2017 Jul; 7(1):6723. PubMed ID: 28751743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure.
    Palese F; Bonomi E; Nuzzo T; Benussi A; Mellone M; Zianni E; Cisani F; Casamassa A; Alberici A; Scheggia D; Padovani A; Marcello E; Di Luca M; Pittaluga A; Usiello A; Borroni B; Gardoni F
    Neurobiol Aging; 2020 Feb; 86():143-155. PubMed ID: 31784278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice.
    Scheggia D; Stanic J; Italia M; La Greca F; Zianni E; Benussi A; Borroni B; Di Luca M; Gardoni F
    Brain Behav Immun; 2021 Oct; 97():89-101. PubMed ID: 34246733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features.
    Italia M; Salvadè M; La Greca F; Zianni E; Pelucchi S; Spinola A; Ferrari E; Archetti S; Alberici A; Benussi A; Solje E; Haapasalo A; Hoffmann D; Katisko K; Krüger J; Facchinetti R; Scuderi C; Padovani A; DiLuca M; Scheggia D; Borroni B; Gardoni F
    Brain Behav Immun; 2024 May; 118():380-397. PubMed ID: 38485064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
    Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
    Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity and Frontotemporal Dementia.
    Alberici A; Cristillo V; Gazzina S; Benussi A; Padovani A; Borroni B
    Curr Alzheimer Res; 2018; 15(7):602-609. PubMed ID: 29357796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a Glutamate Hypothesis of Frontotemporal Dementia.
    Benussi A; Alberici A; Buratti E; Ghidoni R; Gardoni F; Di Luca M; Padovani A; Borroni B
    Front Neurosci; 2019; 13():304. PubMed ID: 30983965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.
    Lines G; Casey JM; Preza E; Wray S
    Mol Cell Neurosci; 2020 Dec; 109():103553. PubMed ID: 32956830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
    Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
    Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid from frontotemporal dementia patients is toxic to neurons.
    Spalloni A; Caioli S; Bonomi E; Zona C; Buratti E; Alberici A; Borroni B; Longone P
    Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166122. PubMed ID: 33713790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.
    Sjögren M; Wallin A
    Mech Ageing Dev; 2001 Nov; 122(16):1923-35. PubMed ID: 11589911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia.
    Marelli C; Hourregue C; Gutierrez LA; Paquet C; Menjot de Champfleur N; De Verbizier D; Jacob M; Dubois J; Maleska AM; Hirtz C; Navucet S; Bennys K; Dumurgier J; Cognat E; Berr C; Magnin E; Lehmann S; Gabelle A
    J Alzheimers Dis; 2020; 74(3):903-911. PubMed ID: 32083577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders.
    Bourbouli M; Rentzos M; Bougea A; Zouvelou V; Constantinides VC; Zaganas I; Evdokimidis I; Kapaki E; Paraskevas GP
    Dement Geriatr Cogn Disord; 2017; 44(3-4):144-152. PubMed ID: 28848086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
    Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
    Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
    Foiani MS; Cicognola C; Ermann N; Woollacott IOC; Heller C; Heslegrave AJ; Keshavan A; Paterson RW; Ye K; Kornhuber J; Fox NC; Schott JM; Warren JD; Lewczuk P; Zetterberg H; Blennow K; Höglund K; Rohrer JD
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):740-746. PubMed ID: 30981993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?
    Cavazzana I; Alberici A; Bonomi E; Ottaviani R; Kumar R; Archetti S; Manes M; Cosseddu M; Buratti E; Padovani A; Tincani A; Franceschini F; Borroni B
    J Neuroimmunol; 2018 Dec; 325():61-63. PubMed ID: 30391902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.
    Landqvist Waldö M; Frizell Santillo A; Passant U; Zetterberg H; Rosengren L; Nilsson C; Englund E
    BMC Neurol; 2013 May; 13():54. PubMed ID: 23718879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.